| Name | 4-[2-(3-nitrophenoxy)ethyl]morpholine |
|---|---|
| Synonyms |
3-[2-(N-Morpholino)ethoxy]-1-nitrobenzene
4-[2-(3-nitro-phenoxy)-ethyl]-morpholine |
| Molecular Formula | C12H16N2O4 |
|---|---|
| Molecular Weight | 252.26600 |
| Exact Mass | 252.11100 |
| PSA | 67.52000 |
| LogP | 1.76690 |
| Risk Phrases | R20/21/22-34 |
|---|---|
| Safety Phrases | S26 |
| RIDADR | UN 3261 |
|
~96%
182618-90-2 |
| Literature: RIGEL PHARMACEUTICALS, INC. Patent: WO2007/30680 A2, 2007 ; Location in patent: Page/Page column 152 ; WO 2007/030680 A2 |
|
~%
182618-90-2 |
| Literature: Merck Sharp and Dohme Ltd. Patent: US5556969 A1, 1996 ; US 5556969 A |
| Precursor 4 | |
|---|---|
| DownStream 1 | |